Graham Capital Management »

Intellia Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $242k 11k 22.38
2022-09-30 $1.0M 18k 55.95

More positions owned by Graham Capital Management

Microstrategy Cl A New Put Option (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Microstrategy Note 2/1 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Vaneck Etf Trust Junior Gold Mine Call Option (GDXJ)
Tilray Brands Note 5.200% 6/1 (Principal)
Novavax Note 5.000%12/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Penn Entertainment Note 2.750% 5/1 (Principal)
Coinbase Global Note 0.500% 6/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
BlackRock
Vanguard Group
Deep Track Capital
State Street Corporation
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Federated Investors
Geode Capital Management
Morgan Stanley
Contrarius Investment Management
Casdin Capital
Alliancebernstein
Dimensional Fund Advisors

View all funds holding Intellia Therapeutics